Mastocytosis: Molecular mechanisms and clinical disease heterogeneity

Leukemia Research

Volumn 25, Issue 7, 2001, Pages 577-582

  Metcalfe, Dean D ^a   Akin, Cem ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Mastocytosis; Mutation; Stem cell factor

Indexed keywords

CD34 ANTIGEN; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL PROLIFERATION; CLINICAL FEATURE; DISEASE COURSE; GENETIC POLYMORPHISM; HUMAN; MAST CELL; MUTATION; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS;

EID: 0034992893     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00046-7     Document Type: Short Survey

References (34)

1. Rare forms of urticaria
2. Beitrage zur anatomie und pathogeneses der urticaria simplex und pigmentosa
3. Urticaria pigmentosa. A report of a case with autopsy
4. Mastocytosis and the skin
5. Gastroentestinal abnormalities and involvement in systemic mastocytosis
6. Bone marrow findings in systemic mastocytosis
7. Adult-onset urticaria pigmentosa and systemic mast cell disease
8. Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosis
9. Hepatic involvement in mastocytosis: Clinicopathologic correlations in 41 cases
10. Serum tryptase and the laboratory diagnosis of systemic mastocytosis
11. Analysis of plasma histamine levels in patients with mast cell disorders
12. Soluble stem cell factor receptor (CD117) and IL-2 receptor (CD25) levels in the plasma of patients with mastocytosis: Correlation with clinical severity and bone marrow pathology
13. Treatment of systemic mast cell disorders
14. v mice and their increase by bone marrow transplantation
15. d anemic mice
16. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus
17. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene
18. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms
19. Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles
20. The c-kit ligand: A cell surface molecule altered in steel mutant fibroblasts
21. + bone marrow progenitor cells
22. + pluripotent progenitor cells
23. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit ligand in long-term culture
24. εRI-cell population
25. Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in the peripheral blood mononuclear cells of patients with mastocytosis
26. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product
27. Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm
28. Elevated expression of the proto-oncogene c-kit in patients with mastocytosis
29. Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of mastocytosis patients
30. Cytogenetic abnormalities and their lack of relationship to the Asp816Val c-kit mutation in the pathogenesis of mastocytosis
31. c-Kit mutation in a population of patients with mastocytosis
32. Activating and dominant inactivating c-kit catalytic domain mutations in distinct clinical forms of human mastocytosis
33. A proposed classification of mastocytosis incorporating molecular genetics
34. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis